US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

MGRX Mangoceuticals Inc

2.37

-0.08 (-3.27%)

31 Dic 2024 - Cerrado

Retrasado por 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

06/18/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Alex P. Hamilton

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Mangoceuticals (NASDAQ:MGRX)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025

Haga Click aquí para más Gráficas Mangoceuticals.

Mangoceuticals (NASDAQ:MGRX)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025

Haga Click aquí para más Gráficas Mangoceuticals.

Noticias sobre Mangoceuticals Inc MGRX

Form 8-K - Current report
Jueves 26 de Diciembre 2024 (6 días hace) • Edgar (US Regulatory)

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent
Jueves 19 de Diciembre 2024 (2 semanas hace) • GlobeNewswire Inc.

Form 8-K - Current report
Jueves 19 de Diciembre 2024 (2 semanas hace) • Edgar (US Regulatory)

Form 8-K - Current report
Viernes 6 de Diciembre 2024 (4 semanas hace) • Edgar (US Regulatory)

Mangoceuticals, Inc. Initiates Investigation into Potential Stock Manipulation Scheme Following Recent Reverse Stock Split
Miércoles 4 de Diciembre 2024 (4 semanas hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jueves 14 de Noviembre 2024 (2 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Martes 12 de Noviembre 2024 (2 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Jueves 31 de Octubre 2024 (2 meses hace) • Edgar (US Regulatory)

Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Jueves 31 de Octubre 2024 (2 meses hace) • GlobeNewswire Inc.

Form 8-K - Current report
Viernes 25 de Octubre 2024 (2 meses hace) • Edgar (US Regulatory)

Form 8-K - Current report
Martes 22 de Octubre 2024 (2 meses hace) • Edgar (US Regulatory)

MangoRx Announces Formation of Strategy and Alternatives Committee
Martes 22 de Octubre 2024 (2 meses hace) • GlobeNewswire Inc.

Más de Mangoceuticals Inc Artículos de Noticias

Bank of America

Verizon Communications

Deutsche Telekom (QX)

BNP Paribas (QX)

JP Morgan Chase

Health Care Select Sector

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones